Why I think this ORMP stock should be trading above $15 soon
A. Plenty of cash - $25M (most of the cash are in short-term investment right now) to support the company research and operation for at least 2 - 3 years or maybe 5 years since last year the company only spent a few millions cash. Stock offering at $10 last December.
B. The major insider and management are buying between $10.15 - $16.35 this year showing the confidence.
C. 1M shares out of 7M total floating shares were short, they have to cover sooner or later.
D. FDA trial is going through much quicker than other companies like Mankind. Now we are at Phase IIb, the next and final would be Phase III which would be next year.
E. This company is a Israel company. Remember Jewish people controls wall street, most of wealth, media and political powers in US, they know the FDA rules well which makes their medical drug easier to pass FDA test.
F. Once their drug passes FDA approval, this could easily become a $50 - $100 stock since it's market capital right is only less than $100M.
G. I have noticed signals of continuously institution buying the stock and they are accumulating the shares.
This would make the stock price goes much high with extremely low float at only 7M shares.
We could tell the institution holding increasing in a month.
H. From technical point of view, the high of this year is $31, this stock could easily bounce back to above $20 with a little bit good news say more insider purchasing or partnership with a large company or more positive test result etc.